UnitedHealth Group Total Cost of Revenue increased by 1.1% to $12.82B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.5%, from $12.39B to $12.82B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 13.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.66B | $7.80B | $8.00B | $8.49B | $8.60B | $8.31B | $8.31B | $9.41B | $9.75B | $9.42B | $10.19B | $11.06B | $11.34B | $11.83B | $12.46B | $12.39B | $13.02B | $12.57B | $12.68B | $12.82B |
| QoQ Change | — | +1.9% | +2.5% | +6.1% | +1.3% | -3.4% | +0.1% | +13.1% | +3.6% | -3.3% | +8.2% | +8.5% | +2.6% | +4.4% | +5.3% | -0.6% | +5.1% | -3.5% | +0.9% | +1.1% |
| YoY Change | — | — | — | — | +12.2% | +6.5% | +3.9% | +10.8% | +13.4% | +13.4% | +22.6% | +17.6% | +16.3% | +25.6% | +22.3% | +12.1% | +14.8% | +6.2% | +1.7% | +3.5% |